- call +1-201-465-4211
- email sales@mrinsights.biz
Parenteral drug delivery systems are those devices that inject the medicine doses other than oral route. Parenteral administration route is coined as the most common and efficient for drug delivery of active drug substances with poor bio-availability and drugs with a narrow therapeutic index. For parenteral drug delivery to be an efficient and effective treatment it is often appropriate to uphold systemic drug levels within the therapeutically effective concentration range in cases of long treatment. Overall, the technique seeks to optimize therapeutic index by enabling immediate drug due to the systemic pool in desired quantities.
Scope of the Report:
This report focuses on the Advanced Parenteral drug delivery in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North American market is expected to have the largest market share due to increasing acceptance of technologically advanced healthcare systems and rising patient awareness levels. European market expected to follow North American market. Asia pacific regional market is expected to be the most lucrative due to increasing penetration, greater untapped opportunity and rapidly improving healthcare infrastructure in emerging economies of China and India.
The worldwide market for Advanced Parenteral drug delivery is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
Market Segment by Applications, can be divided into
Government Hospitals
Private Hospitals and Clinics
Healthcare Organizations
Others
There are 15 Chapters to deeply display the global Advanced Parenteral drug delivery market.
Chapter 1, to describe Advanced Parenteral drug delivery Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Advanced Parenteral drug delivery, with sales, revenue, and price of Advanced Parenteral drug delivery, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Advanced Parenteral drug delivery, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Advanced Parenteral drug delivery market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Advanced Parenteral drug delivery sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Advanced Parenteral drug delivery Introduction
1.2 Market Analysis by Type
1.2.1 Prefillable Syringes
1.2.2 Injectors Cartridges
1.2.3 Hypodermic Syringes
1.2.4 IV Catheters
1.2.5 Other Parenteral Delivery Devices
1.3 Market Analysis by Applications
1.3.1 Government Hospitals
1.3.2 Private Hospitals and Clinics
1.3.3 Healthcare Organizations
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Advanced Parenteral drug delivery Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Advanced Parenteral drug delivery Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Advanced Parenteral drug delivery Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Hoffmann-La Roche
2.4.1 Business Overview
2.4.2 Advanced Parenteral drug delivery Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hoffmann-La Roche Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Advanced Parenteral drug delivery Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Baxter
2.6.1 Business Overview
2.6.2 Advanced Parenteral drug delivery Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Baxter Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Dickinson
2.7.1 Business Overview
2.7.2 Advanced Parenteral drug delivery Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Dickinson Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boston Scientific
2.8.1 Business Overview
2.8.2 Advanced Parenteral drug delivery Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Boston Scientific Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bristol-Myers Squibb
2.9.1 Business Overview
2.9.2 Advanced Parenteral drug delivery Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 GlaxoSmithKline
2.10.1 Business Overview
2.10.2 Advanced Parenteral drug delivery Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GlaxoSmithKline Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Novartis
2.11.1 Business Overview
2.11.2 Advanced Parenteral drug delivery Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Novartis Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Becton
2.12.1 Business Overview
2.12.2 Advanced Parenteral drug delivery Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Becton Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 AptarGroup
2.13.1 Business Overview
2.13.2 Advanced Parenteral drug delivery Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 AptarGroup Advanced Parenteral drug delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Advanced Parenteral drug delivery Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Advanced Parenteral drug delivery Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Advanced Parenteral drug delivery Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Advanced Parenteral drug delivery Manufacturer Market Share in 2017
3.3.2 Top 6 Advanced Parenteral drug delivery Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Advanced Parenteral drug delivery Market Analysis by Regions
4.1 Global Advanced Parenteral drug delivery Sales, Revenue and Market Share by Regions
4.1.1 Global Advanced Parenteral drug delivery Sales and Market Share by Regions (2013-2018)
4.1.2 Global Advanced Parenteral drug delivery Revenue and Market Share by Regions (2013-2018)
4.2 North America Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
4.3 Europe Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
4.5 South America Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
5 North America Advanced Parenteral drug delivery by Countries
5.1 North America Advanced Parenteral drug delivery Sales, Revenue and Market Share by Countries
5.1.1 North America Advanced Parenteral drug delivery Sales and Market Share by Countries (2013-2018)
5.1.2 North America Advanced Parenteral drug delivery Revenue and Market Share by Countries (2013-2018)
5.2 United States Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
5.3 Canada Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
5.4 Mexico Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
6 Europe Advanced Parenteral drug delivery by Countries
6.1 Europe Advanced Parenteral drug delivery Sales, Revenue and Market Share by Countries
6.1.1 Europe Advanced Parenteral drug delivery Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Advanced Parenteral drug delivery Revenue and Market Share by Countries (2013-2018)
6.2 Germany Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
6.3 UK Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
6.4 France Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
6.5 Russia Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
6.6 Italy Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
7 Asia-Pacific Advanced Parenteral drug delivery by Countries
7.1 Asia-Pacific Advanced Parenteral drug delivery Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Advanced Parenteral drug delivery Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Advanced Parenteral drug delivery Revenue and Market Share by Countries (2013-2018)
7.2 China Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
7.3 Japan Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
7.4 Korea Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
7.5 India Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
8 South America Advanced Parenteral drug delivery by Countries
8.1 South America Advanced Parenteral drug delivery Sales, Revenue and Market Share by Countries
8.1.1 South America Advanced Parenteral drug delivery Sales and Market Share by Countries (2013-2018)
8.1.2 South America Advanced Parenteral drug delivery Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
8.3 Argentina Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
8.4 Colombia Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
9 Middle East and Africa Advanced Parenteral drug delivery by Countries
9.1 Middle East and Africa Advanced Parenteral drug delivery Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Advanced Parenteral drug delivery Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Advanced Parenteral drug delivery Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
9.3 UAE Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
9.4 Egypt Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
9.5 Nigeria Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
9.6 South Africa Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
10 Global Advanced Parenteral drug delivery Market Segment by Type
10.1 Global Advanced Parenteral drug delivery Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Advanced Parenteral drug delivery Sales and Market Share by Type (2013-2018)
10.1.2 Global Advanced Parenteral drug delivery Revenue and Market Share by Type (2013-2018)
10.2 Prefillable Syringes Sales Growth and Price
10.2.1 Global Prefillable Syringes Sales Growth (2013-2018)
10.2.2 Global Prefillable Syringes Price (2013-2018)
10.3 Injectors Cartridges Sales Growth and Price
10.3.1 Global Injectors Cartridges Sales Growth (2013-2018)
10.3.2 Global Injectors Cartridges Price (2013-2018)
10.4 Hypodermic Syringes Sales Growth and Price
10.4.1 Global Hypodermic Syringes Sales Growth (2013-2018)
10.4.2 Global Hypodermic Syringes Price (2013-2018)
10.5 IV Catheters Sales Growth and Price
10.5.1 Global IV Catheters Sales Growth (2013-2018)
10.5.2 Global IV Catheters Price (2013-2018)
10.6 Other Parenteral Delivery Devices Sales Growth and Price
10.6.1 Global Other Parenteral Delivery Devices Sales Growth (2013-2018)
10.6.2 Global Other Parenteral Delivery Devices Price (2013-2018)
11 Global Advanced Parenteral drug delivery Market Segment by Application
11.1 Global Advanced Parenteral drug delivery Sales Market Share by Application (2013-2018)
11.2 Government Hospitals Sales Growth (2013-2018)
11.3 Private Hospitals and Clinics Sales Growth (2013-2018)
11.4 Healthcare Organizations Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Advanced Parenteral drug delivery Market Forecast (2018-2023)
12.1 Global Advanced Parenteral drug delivery Sales, Revenue and Growth Rate (2018-2023)
12.2 Advanced Parenteral drug delivery Market Forecast by Regions (2018-2023)
12.2.1 North America Advanced Parenteral drug delivery Market Forecast (2018-2023)
12.2.2 Europe Advanced Parenteral drug delivery Market Forecast (2018-2023)
12.2.3 Asia-Pacific Advanced Parenteral drug delivery Market Forecast (2018-2023)
12.2.4 South America Advanced Parenteral drug delivery Market Forecast (2018-2023)
12.2.5 Middle East and Africa Advanced Parenteral drug delivery Market Forecast (2018-2023)
12.3 Advanced Parenteral drug delivery Market Forecast by Type (2018-2023)
12.3.1 Global Advanced Parenteral drug delivery Sales Forecast by Type (2018-2023)
12.3.2 Global Advanced Parenteral drug delivery Market Share Forecast by Type (2018-2023)
12.4 Advanced Parenteral drug delivery Market Forecast by Application (2018-2023)
12.4.1 Global Advanced Parenteral drug delivery Sales Forecast by Application (2018-2023)
12.4.2 Global Advanced Parenteral drug delivery Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Advanced Parenteral drug delivery Picture
Table Product Specifications of Advanced Parenteral drug delivery
Figure Global Sales Market Share of Advanced Parenteral d
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
